TABLE 4.
With mutation and/or CNV* | Without mutation nor CNV* | p | ||
---|---|---|---|---|
Age | <=60 | 90 | 17 | 0.019 |
>60 | 278 | 24 | ||
Gender | Female | 97 | 9 | 0.541 |
Male | 271 | 32 | ||
Pathological TNM Stages |
Ⅰ | 1 | 1 | 0.026 |
Ⅱ | 112 | 18 | ||
Ⅲ | 124 | 15 | ||
Ⅳ | 129 | 7 | ||
N/A | 2 | 0 | ||
T stage | T1 | 2 | 1 | 0.125 |
T2 | 103 | 15 | ||
T3 | 174 | 18 | ||
T4 | 56 | 2 | ||
Tx | 29 | 3 | ||
M stage | M0 | 166 | 27 | 0.993 |
M1 | 10 | 1 | ||
Mx | 187 | 11 | ||
N stage | N0 | 204 | 31 | 0.02 |
N1 | 44 | 1 | ||
N2 | 73 | 3 | ||
N3 | 7 | 0 | ||
Nx | 33 | 3 | ||
Histological Grade | low | 13 | 8 | <0.001 |
high | 352 | 33 | ||
N/A | 3 | 0 |
A chi‐square test was applied for analysis and p < 0.05 was considered significant.
With mutation and/or CNV: Cases have mutant or CNV or mutant and CNV, confirmed through TCGA database. Without mutant nor CNV: Cases with neither mutant nor CNV, confirmed through TCGA database. Ambiguous variables (Nx, Mx, N/A and Gx) were excluded from chi‐square test or non‐parametric test.